Media coverage
5
Media coverage
Title Ozempic and Wegovy can reverse heart disease symptoms: Slimming jabs offer hopes of cure as study suggests key ingredient semaglutide is three times more effective than existing treatments Media name/outlet Mail online Media type Web Country/Territory United Kingdom Date 25/08/23 Description Weight loss jabs can reverse symptoms of heart disease in a major breakthrough offering hope to half a million Britons.
A landmark global trial found semaglutide - known under brand names Ozempic and Wegovy – was three times more effective than any existing treatments for heart failure.
Experts said the new class of weight-loss drugs will herald a ‘new era’, transforming the lives of patients with the deadly disease.URL https://www.dailymail.co.uk/health/article-12445167/Ozempic-Wegovy-reverse-heart-disease-symptoms.html Persons Fozia Ahmed Title Weight-loss drug Wegovy produces ‘largest benefitever seen’ for patients with most common form of heartfailure, trial finds Media name/outlet CNN Country/Territory United States Date 25/08/23 Description A study found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weightloss, led to an improvement of 17 points on a 100-point scale that’s used to assesssymptoms of a condition known as heart failure with preserved ejection fraction. URL https://edition.cnn.com/2023/08/25/health/wegovy-semaglutide-heart-failure/index.html Persons Fozia Ahmed Title Weight-loss drug can reverse heart failure symptoms, study finds Media name/outlet The Guardian Country/Territory United Kingdom Date 25/08/23 Description Semaglutide injections trigger ‘very large improvements’ in patients with hearts too stiff to fill properly URL https://www.theguardian.com/society/2023/aug/25/weight-loss-drug-semaglutide-reverses-heart-failure-symptoms-study Persons Fozia Ahmed Title Wegovy Scores HFpEF Benefits in People With Obesity Media name/outlet Medscape Country/Territory United States Date 25/08/23 Description Adults with heart failure with preserved ejection fraction (HFpEF) but without diabetes showed significant improvements in their heart failure-related symptoms and physical limitations, exercise function, and weight loss when treated with a weight-reducing dose of semaglutide for 52 weeks compared with placebo in the randomized STEP-HFpEF trial. URL https://www.medscape.com/viewarticle/995844?form=fpf Persons Fozia Ahmed Title https://www.thetimes.co.uk/article/weight-loss-injections-ozempic-could-be-key-curing-heart-failure-5cbgx6x88 Media name/outlet The Times Country/Territory United Kingdom Date 25/08/23 Description Weight loss injections are three times more effective than any previous drug at treating heart failure, a landmark trial has found.
The new generation of anti-obesity drugs offer hope of the first cure for heart failure, a debilitating condition that affects one million people in Britain.URL https://www.thetimes.co.uk/article/weight-loss-injections-ozempic-could-be-key-curing-heart-failure-5cbgx6x88 Persons Fozia Ahmed